Quest Diagnostics DGX
Quest Diagnostics is the 346th largest S&P 500 company by market cap, worth $26.6 billion. 11 directors have filed with the SEC in the last 12 months (who counts), 1 of them an executive. 7 other officers are on file. At 30 Jun 2026, Vanguard was its largest institutional holder, with 13.2% of the company.
- CEO
- J. E. Davis
- Sector
- Health Care
- Sub-industry
- Health Care Services
- Headquarters
- Secaucus, New Jersey
- Founded
- 1967
- More
- Wikipedia
- Market cap
- $26.6B
- 346th largest, 23 Oct 2026 close
- Price to sales
- 2.4
- Market cap over revenue
- Market cap per employee
- $467K
- Market cap over employees
- Connections
- 6
- S&P 500 companies sharing a director or officer
Largest institutional holders
Each fund group's share of Quest Diagnostics. Where a company has several share classes, the share is of its total value.
13F filings for the quarter to 30 Jun 2026
Board and officers
5 people here also hold roles at other S&P 500 companies.
Roles filed up to 30 Sep 2026
| Name | Title |
|---|---|
| Directors (11) | |
| J. E. DavisCEO and President | |
| Robert B. CarterDirector | |
| Luis DiazDirector | |
| Tracey DoiDirectorAlso at Pentair | |
| Vicky B. GreggDirector | |
| Wright Lassiter IIIDirectorAlso at Fortive | |
| Timothy L. MainDirector | |
| Denise M. MorrisonDirectorAlso at MetLife and Visa | |
| Gary M. PfeifferDirector | |
| Timothy M. RingDirectorAlso at Becton Dickinson | |
| Timothy C. WentworthDirector | |
| Officers (7) | |
| Sam SamadExecutive Vice President & CFOAlso at Idexx LaboratoriesLast filed 27 Jul 2026 | |
| Mark E. DelaneySVP & Chief Commercial OfficerLast filed 29 Jul 2026 | |
| Michael J. DeppeSVP, Corp. Controller & CAOLast filed 6 Mar 2026 | |
| Catherine T. DohertyEVP, Regional BusinessesLast filed 6 Mar 2026 | |
| Karthik KuppusamySVP, Clinical SolutionsLast filed 27 Jul 2026 | |
| Patrick PlewmanSVP for Diagnostic ServicesLast filed 27 Jul 2026 | |
| Michael E. PrevoznikSVP & General CounselLast filed 31 Aug 2026 | |
Companies that share people with Quest Diagnostics
Each person's title here, then at the other company.
- Becton Dickinson BDX
- Timothy M. Ring: Director here, Director there
- Fortive FTV
- Wright Lassiter III: Director here, Director there
- Idexx Laboratories IDXX
- Sam Samad: Executive Vice President & CFO here, Director there
- MetLife MET
- Denise M. Morrison: Director here, Director there
- Pentair PNR
- Tracey Doi: Director here, Director there
- Visa V
- Denise M. Morrison: Director here, Director there
Quest Diagnostics' market cap since December 2008
Weekly, up to 23 Oct 2026
| Week ending | Market cap |
|---|---|
| 23 Oct 2026 | $26.6B |
| 26 Dec 2025 | $19.6B |
| 27 Dec 2024 | $17.0B |
| 29 Dec 2023 | $15.5B |
| 30 Dec 2022 | $17.8B |
| 31 Dec 2021 | $21.2B |
| 25 Dec 2020 | $16.2B |
| 27 Dec 2019 | $14.4B |
| 28 Dec 2018 | $11.2B |
| 29 Dec 2017 | $13.4B |
| 30 Dec 2016 | $12.7B |
| 25 Dec 2015 | $10.2B |
| 26 Dec 2014 | $9.8B |
| 27 Dec 2013 | $7.9B |
| 28 Dec 2012 | $9.2B |
| 30 Dec 2011 | $9.2B |
| 31 Dec 2010 | $9.2B |
| 25 Dec 2009 | $11.4B |
| 26 Dec 2008 | $9.8B |
Download Quest Diagnostics' data as JSON, with the weekly market caps in billions of dollars from 5 Dec 2008.
Workforce
Headcount at 31 Dec 2025
- Employees
- 57,000
As of December 31, 2025, we have nearly 57,000 employees globally (including LifeLabs’ approximately 6,800), of whom approximately 46,000 are full-time and the remainder are part-time or on-call.
Insider trades
Open-market buys and sales by directors and officers. Grants, option exercises and shares withheld for tax are left out.
Trades from 30 Sep 2025 to 30 Sep 2026
Directors and officers sold $37.3 million of stock in 22 sales and made no open-market purchases in the 12 months to 30 Sep 2026.
| Date | Person | Value |
|---|---|---|
| 1 Sep 2026Sale | J. E. DavisCEO and President | $2.4M |
| 28 Aug 2026Sale | Michael E. PrevoznikSVP & General Counsel | $5.5M |
| 28 Jul 2026Sale | Mark E. DelaneySVP & Chief Commercial Officer | $376K |
| 4 Jun 2026Sale | Karthik KuppusamySVP, Clinical Solutions | $1.6M |
| 1 Jun 2026Sale | J. E. DavisCEO and President | $1.9M |
| 5 Mar 2026Sale | Catherine T. DohertyEVP, Regional Businesses | $1.1M |
| 5 Mar 2026Sale | Michael E. PrevoznikSVP & General Counsel | $800K |
| 5 Mar 2026Sale | Patrick PlewmanSVP for Diagnostic Services | $589K |
| 4 Mar 2026Sale | Karthik KuppusamySVP, Clinical Solutions | $538K |
| 3 Mar 2026Sale | Catherine T. DohertyEVP, Regional Businesses | $131K |
Showing 10 of 22 trades
Trades by members of Congress and officials
Trades members of Congress and senior executive branch officials disclosed, including their families'. Amounts are filed as ranges.
Trades from 20 Oct 2023 to 20 Oct 2026
9 people disclosed 9 purchases and 12 sales of Quest Diagnostics stock since October 2023.
| Date | Member or official | Amount |
|---|---|---|
| 4 Sep 2026 | Rohit KhannaHouse, D-CA · Bought | $1K to $15K |
| 23 Jul 2026 | Donald J TrumpPresident · Sold | $15K to $50K |
| 12 Jun 2026 | Donald J TrumpPresident · Sold | $1K to $15K |
| 18 May 2026 | Donald J TrumpPresident · Bought | $100K to $250K |
| 11 May 2026 | Donald J TrumpPresident · Bought | $100K to $250K |
| 30 Mar 2026 | Alan ArmstrongSenate, R-OK · Bought | $1K to $15K |
| 27 Mar 2026 | Alan ArmstrongSenate, R-OK · Bought | $1K to $15K |
| 29 Jan 2026 | Rohit KhannaHouse, D-CA · Bought | $1K to $15K |
| 3 Nov 2025 | Julie JohnsonHouse, D-TX · Sold | $1K to $15K |
| 30 Oct 2025 | Julie JohnsonHouse, D-TX · Sold | $1K to $15K |
Showing 10 of 21 trades
Not on file: no WARN layoff notices under its own name since October 2023.